Skip to main content
. 2019 Nov 29;11(12):637. doi: 10.3390/pharmaceutics11120637

Table 2.

Optimisation results with different weighting factors in the objective function.

Weighting Factor, w1, for the Systemic Plasma Conc. Weighting Factor, w2, for the Intracellular Conc. kr37 (10−4 s−1) kr42 (s−1) Hyperthermia Duration (s) Systemic Plasma Concentration (μg/mL) Intracellular Concentration (ng/105 cells)
0 1 0.3 1.14 3600 0.26 0.56
0.25 0.75 0.3 1.1 3600 0.25 0.56
0.5 0.5 0.3 0.7 3600 0.24 0.55
0.75 0.25 0.3 0.13 3600 0.21 0.48
1 0 0.3 0.0114 3600 0.18 0.19